Trailing-twelve-month (TTM) revenue is $13.86 Million with a year-over-year growth of (82.91%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,260,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $6,237,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $1,046,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $3,320,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $13,863,000 |
Current P/S: $200,955,250 market capitalization ÷ $13,863,000 TTM revenue = 14.50x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.32M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:00:57.470Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2021-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD |
|---|---|
| Phase Three License | $173M |
$13.86M
$13.86 Million
(82.91%)
vs. $81.12M a year ago (TTM)
(8.35%)
5 Year compound annual growth rate
1 Year
(82.91%)
3 Year
(48.59%)
5 Year
(8.35%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $21.05M | ($79.51M) | (79.07%) |
| 2024 | $100.56M | +$3.50M | +3.60% |
| 2023 | $97.06M | ($36.55M) | (27.36%) |
| 2022 | $133.62M | ($73.47M) | (35.48%) |
| 2021 | $207.09M | +$185.99M | +881.54% |
| 2020 |
TTM Growth
(82.91%)
3-Year CAGR
(48.59%)
5-Year CAGR
(8.35%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:00:57.470Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $21.10M |
| ($121,000) |
| (0.57%) |
| 2019 | $21.22M | ($6.46M) | (23.33%) |
| 2018 | $27.68M | +$23.94M | +641.02% |
| 2017 | $3.73M | +$3.32M | +797.84% |
